prof. Tessa Kerre

Journal Article

Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients

Matthijs Oyaert (UGent) , Marie-Angélique De Scheerder (UGent) , Sophie Van Herrewege, Guy Laureys (UGent) , Sofie Van Assche, Melissa Cambron (UGent) , Leslie Naesens (UGent) , Levi Hoste (UGent) , Karlien Claes (UGent) , Filomeen Haerynck (UGent) , et al.

(2023) EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.

Add to list

Journal Article
A1
open access

The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation

Melissa Pille (UGent) , John Avila, Guillem Sanchez Sanchez, Glenn Goetgeluk (UGent) , Stijn De Munter (UGent) , Hanne Jansen (UGent) , Lore Billiet (UGent) , Karin Weening (UGent) , Haipeng Xue, Sarah Bonte (UGent) , et al.

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective analysis

Sophie Servais, Frederic Baron, Chantal Lechanteur, Laurence Seidel, Etienne Baudoux, Alexandra Briquet, Dominik Selleslag, Johan Maertens, Xavier Poire, Wilfried Schroyens, et al.

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma : a systematic literature review

Stephen Jolles, Sergio Giralt, Tessa Kerre (UGent) , Hillard M. Lazarus, S. Shahzad Mustafa, Roberto Ria and Donald C. Vinh

(2023) FRONTIERS IN ONCOLOGY. 13.

Add to list

Journal Article
A1
open access

Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma : recommendations from an international expert panel

Stephen Jolles, Sergio Giralt, Tessa Kerre (UGent) , Hillard M. Lazarus, S. Shahzad Mustafa, Genovefa A. Papanicolaou, Marcel Reiser, Roberto Ria, Donald C. Vinh and John R. Wingard

(2023) BLOOD REVIEWS. 58.

Add to list

Miscellaneous
open access

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion

Stijn De Munter (UGent) , Juliane Buhl, Laurenz De Cock (UGent) , Alexander Van Parys (UGent) , Willem Daneels (UGent) , Eva Pascal (UGent) , Lucas Deseins (UGent) , Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Lore Billiet (UGent) , et al.

(2023) BioRxiv.

Add to list

Journal Article
A1
open access

Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage

Lore Billiet (UGent) , Laurenz De Cock (UGent) , Guillem Sanchez Sanchez, Rupert Mayer (UGent) , Glenn Goetgeluk (UGent) , Stijn De Munter (UGent) , Melissa Pille (UGent) , Joline Ingels (UGent) , Hanne Jansen, Karin Weening (UGent) , et al.

(2023) JOURNAL OF EXPERIMENTAL MEDICINE. 220(6).

Add to list

Added value of baseline chest CT scan for IPA diagnosis in AML patients receiving intensive chemotherapy : a retrospective single-centre cohort study

Sammy Huygens (UGent) , Emilie Janssens, Ine Moors (UGent) , Tessa Kerre (UGent) , Anke Delie (UGent) , Lieve Morbée (UGent) and Alexander Schauwvlieghe (UGent)

(2023) 38th General Annual Meeting of the Belgian Hematology Society 2023, Abstracts.

Add to list

Phase 2 CARTITUDE-2 study (cohort B) : updated clinical data and biological correlative analyses of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy

Mounzer Agha, Niels W. C. J. van de Donk, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre (UGent) , Wilfried Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Helen Varsos, et al.

(2022) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 22(Supplement 2). p.S408-S409

Add to list

Ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2 cohort B 18-month follow-up

Niels W. C. J. Van de Donk, Mounzer Agha, Adam D. Cohen, Yael C. Cohen, Sebastien Anguille, Tessa Kerre (UGent) , Wilfried W. H. Roeloffzen, Jordan M. Schecter, Kevin C. De Braganca, Carolyn C. Jackson, et al.

(2022) BLOOD. In Blood 140(Supplement 1). p.7536-7537

Academic Bibliography

prof. Tessa Kerre

Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients

The Wiskott–Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective analysis

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma : a systematic literature review

Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma : recommendations from an international expert panel

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen induced exhaustion

Single-cell profiling identifies a novel human polyclonal unconventional T cell lineage

Added value of baseline chest CT scan for IPA diagnosis in AML patients receiving intensive chemotherapy : a retrospective single-centre cohort study

Phase 2 CARTITUDE-2 study (cohort B) : updated clinical data and biological correlative analyses of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy

Ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR-T cell therapy, in patients with multiple myeloma (MM) and early relapse after initial therapy : CARTITUDE-2 cohort B 18-month follow-up

Contents

Support

Contact